OGDHL is involved in the tricarboxylic acid cycle, and frequently down-regulated in human carcinoma and suppresses tumor growth, which could be a predictive factor for worse prognosis in patients with pancreatic cancer [23]. The gene discussed is OGDHL; the disease is familial pancreatic carcinoma.